We’re celebrating spooky season with a parasite’s worst nightmare. Today, the U.S. Food and Drug Administration (FDA) approves Credelio QuattroTM (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) becoming the broadest* approved canine oral parasiticide with its protection against six types of parasites—fleas, ticks, heartworms, and the three risky intestinal parasites—roundworms, hookworms** and tapeworms in a single monthly chewable tablet for dogs eight weeks of age or older and weighing 3.3 pounds or greater.
?Starts to kill ticks*** and fleas in just 4 hours.
??Kills >99% of fleas within 8 hours of administration and 100% in the first day and remains effective for an entire month.
??Provides coverage against internal parasites with zoonotic potential, meaning parasites that have the potential to infect people as well as pets, it’s very easy to go from ‘ick’ to ‘sick.’
4?? Credelio Quattro is the newest addition to the Credelio? (lotilaner) franchise and the first FDA-approved parasiticide product with four active ingredients.
Learn more about Credelio Quattro: https://lnkd.in/g4VXUWJp
#WeAreElanco
Indications: Credelio Quattro is for the prevention of heartworm disease for the treatment and control of roundworm, hookworm** and tapeworm infections. Credelio Quattro kills adult fleas and is for the treatment and prevention of flea infestations and the treatment and control of tick infestations for 1 month in dogs and puppies 8 weeks of age and older and weighing 3.3 pounds or greater.
Important Safety Information: Lotilaner, an ingredient in Credelio Quattro, belongs to the isoxazoline class and has been associated with neurologic adverse reactions like tremors, ataxia, and seizures even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Dogs should be tested for existing heartworm infections before Credelio Quattro administration as it is not effective against adult D. immitis. The safe use in breeding, pregnant, or lactating dogs has not been evaluated. The most frequently reported adverse reactions in clinical trials were vomiting and diarrhea. For complete safety information, please see Credelio Quattro product label or ask your veterinarian,
https://lnkd.in/gnAA5gY4.
*Based on label comparison of number of parasites types covered.
** Uncinaria stenocephala
*** Ixodes ricinus